Southern Blood Cancer Conference: Saturday, October 25, 2025

Click here to print the full agenda.

 

 

 

9:00 am ET 10:00 am ET Registration, Exhibits & Breakfast  
10:00 am  11:00 am 

Welcome & Opening Remarks

 

 


Keynote Presentation:
Rethinking Life After Cancer

Kim Nickels
Senior Manager, Patient & Community Outreach
The Leukemia & Lymphoma Society 

 

Damion Davis, PhD, LPC
Davis Counseling Center, PLLC

11:00 am  11:15 am   Break & Exhibitor Session  
11:15 am  12:15 pm Concurrent Breakout Sessions  
    Adult Acute Leukemias (ALL & AML) Joseph Maakaron, MD
The Blood and Marrow Transplant Program at Northside Hospital
    Chronic Myeloid Leukemia (CML) Ravi Bhatia, MD
UAB Medicine
    Lymphoma Low Grade Mary Ninan, MD
The Blood and Marrow Transplant Program at Northside Hospital
    Myelodysplastic Syndromes (MDS) Joseph Rimando, MD
Winship Cancer Institute of Emory University
    CAR-T Cell Therapy: Mechanism, Toxicities and Future Directions Hong De Sa, MD
The Blood and Marrow Transplant Program at Northside Hospital
    The Road Ahead: A Guide to Blood Cancer Survivorship Carlos Lopez, MD, MPH
Winship Cancer Institute of Emory University
12:15 pm 12:30 pm  Break & Exhibitor Session  
12:30 pm 1:00 pm Lunch  
1:00 pm 1:15 pm  Break & Exhibitor Session  
1:15 pm   2:15 pm   Concurrent Breakout Sessions  
    Chronic Lymphocytic Leukemia (CLL)     Locke J. Bryan, MD
Georgia Cancer Center, Augusta University Medical Center 
    Lymphoma High Grade & Hodgkin Lymphoma   Leslie Popplewell, MD
City of Hope
    Multiple Myeloma Nishi Nilesh Shah, MBBS, MPH
Winship Cancer Institute of Emory University
    Myeloproliferative Neoplasms (MPN) Michael Hochman, MD
Winship Cancer Institute of Emory University
    CAR-T Cell Therapy: Mechanism, Toxicities and Future Directions Hong De Sa, MD
The Blood and Marrow Transplant Program at Northside Hospital
    The Road Ahead: A Guide to Blood Cancer Survivorship Carlos Lopez, MD, MPH
Winship Cancer Institute of Emory University
2:15 pm  2:30 pm Evaluations & Conference Concludes  

Follow LLS